Search

everythinglearnresearchcommunity

for

Search:↓

Trichotillomania can cause severe complications like hairballs in the stomach, needing surgery and psychiatric care.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Alopecia areata may be linked to hearing problems, so patients should monitor their hearing.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Hair growth dysfunction involves various conditions with limited treatment options.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Thyroid hormones affect skin texture, hair and nail growth, and can cause skin diseases related to thyroid problems.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.